HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Cardiovascular Translational Research
Cardiovascular Translational Research
It is integrated research into the pathogenesis, diagnosis, and treatment of cardiovascular disease. The Strategic Plan’s clinical and translational research goals emphasize the transmission of knowledge between basic and clinical research so that findings in one arena rapidly inform and stimulate research in the cardiovascular field.
Committee Members
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical College, United States
Yochai Birnbaum
Baylor College of Medicine, United States Heart Congress 2025 Speakers
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United StatesSubmit your abstract Today
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Association of red blood cell distribution width with mortality in type A aortic dissection after surgery
Bufan Zhang, Tianjin Medical University General Hospital, China
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States